CN Patent

CN117205164B — 一种盐酸沙丙蝶呤片剂及其制备方法

Assigned to Shandong New Time Pharmaceutical Co Ltd · Expires 2024-07-26 · 2y expired

What this patent protects

本发明属于药物制剂技术领域，具体涉及一种盐酸沙丙蝶呤片剂及其制备方法。该片剂包含盐酸沙丙蝶呤、麦芽糖醇、羟乙甲纤维素和药学上可接受的其他辅料。该片剂气味香甜易于咀嚼，可实现溶出度高、生物利用度高，稳定性好，制备工艺简单。

USPTO Abstract

本发明属于药物制剂技术领域，具体涉及一种盐酸沙丙蝶呤片剂及其制备方法。该片剂包含盐酸沙丙蝶呤、麦芽糖醇、羟乙甲纤维素和药学上可接受的其他辅料。该片剂气味香甜易于咀嚼，可实现溶出度高、生物利用度高，稳定性好，制备工艺简单。

Drugs covered by this patent

Patent Metadata

Patent number
CN117205164B
Jurisdiction
CN
Classification
—
Expires
2024-07-26
Drug substance claim
No
Drug product claim
No
Assignee
Shandong New Time Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.